$Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients$

Treatment Choices Based On Multiplatform Profiling Platform, Unlike Those With Sequencing Alone, Do Not Cause A Cost Explosion In Refractory Cancer Patients

OBJECTIVES: Molecular testing of cancers is quickly becoming standard of care using diverse approaches, either academic or commercial in origin. Some oncologists remain apprehensive about the clinical utility of molecular profiling, based on the degree to which information can be used in a treatment...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Value in health 2017-10, Vol.20 (9), p.A579
Hauptverfasser:	Russell, KJ, Janssens, J, Dean, A, Hernandez, A, Voss, A
Format:	Artikel
Sprache:	eng
Schlagworte:	Anxiety Cancer Costing Health care expenditures Intelligence Medical diagnosis Medical treatment Oncologists Patients Profiles Systematic review Treatment preferences
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!